Medicine and Dentistry
Positron Emission Tomography
100%
Neoplasm
91%
Polyethylene Terephthalate
79%
Positron Emission Tomography-Computed Tomography
60%
Fluorine-18
51%
Fluorodeoxyglucose F 18
41%
Prostate Cancer
33%
Fluorodeoxyglucose
23%
Radioactive Tracer
23%
Gallium 68
23%
Molecular Imaging
20%
Prostate Specific Membrane Antigen
20%
Radiation Therapy
19%
Malignant Neoplasm
16%
Magnetic Resonance Imaging
15%
Ganglioglioma
13%
Breast Cancer
12%
Standardized Uptake Value
12%
Lutetium 177
12%
Lymph Node
11%
Glioblastoma
11%
Diseases
11%
Biodistribution
11%
Overall Survival
11%
Non Small Cell Lung Cancer
11%
Biological Marker
11%
Diagnosis
10%
Computer Assisted Tomography
10%
Carbon 11
10%
Tetraxetan
10%
Chemoradiotherapy
9%
Cancer
9%
Nuclear Medicine
9%
Amino Acid
9%
Treatment Response
8%
Single-Photon Emission Computed Tomography
8%
Intracranial Tumor
8%
Metastatic Carcinoma
8%
Metabolism
8%
Zirconium 89
8%
Methionine
8%
Oncology
8%
Adenocarcinoma
8%
Neoadjuvant Therapy
7%
Clinical Trial
7%
Neuroendocrine Tumor
7%
Hypoxia
7%
Radiation Treatment Planning
6%
Imaging Agent
6%
Prostate Specific Antigen
6%
Keyphrases
Positron Emission Tomography
69%
Tumor
60%
Positron Emission Tomography-computed Tomography (PET-CT)
48%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
33%
Prostate-specific Antigen
26%
PET Imaging
20%
Prostate Cancer
18%
Standardized Uptake Value
17%
18F-fluorodeoxyglucose (18F-FDG)
17%
Lutetium-177 (177Lu)
17%
Molecular Imaging
16%
Biodistribution
15%
FDG Uptake
14%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
14%
Gallium-68
14%
PARP Inhibitor (PARPi)
13%
Tumor Response
12%
18F-FDG PET-CT
11%
Zirconium-89 (89Zr)
11%
Fluorodeoxyglucose
11%
Overall Survival
10%
Lymph Node
10%
Chemotherapy
10%
Single-photon Emission Computed Tomography (SPECT)
10%
Non-responders
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Magnetic Resonance Imaging
10%
FDG PET-CT
10%
Radiotherapy
9%
Treatment Monitoring
9%
Tumor Metabolism
9%
SUVmax
9%
After Injection
9%
Hypoxia
9%
Computed Tomography
9%
Glioma
9%
Radiation Treatment Planning
9%
18F-fluorodeoxyglucose PET
8%
PET Scan
8%
Radiotracer
8%
Response Assessment
8%
Nuclear Medicine
8%
Breast Cancer
8%
Brain Tumor
8%
Glioblastoma
7%
Tumor Tissue
7%
Metabolic Activity
7%
Response Prediction
7%
In Vivo Imaging
7%
Metabolic Imaging
7%